Elicio Therapeutics Inc. (ELTX)
Healthcare
Biotechnology
2.80 $
-3.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Elicio Therapeutics Inc. (ELTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.2% of the shares are freely tradable; institutional investors hold 17.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
17.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
29.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
70.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
14.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
19Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Knoll Capital Management LP | 3.31 | 630,915 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.72 | 518,638 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.60 | 496,901 | +4.9 | 12/31/2025 |
| Balyasny Asset Management LLC | 1.28 | 244,814 | +76.4 | 03/31/2026 |
| Geode Capital Management, LLC | 0.71 | 135,164 | +2.0 | 03/31/2026 |
| Renaissance Technologies Corp | 0.64 | 121,631 | +332.7 | 03/31/2026 |
| Millennium Management LLC | 0.49 | 92,762 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.02 | 384,801 | +0.0 | 04/30/2026 |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 1.31 | 250,000 | +0.0 | 05/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.66 | 126,636 | +4.9 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.